These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24492365)

  • 1. Pharmacokinetics of isoniazid in low-birth-weight and premature infants.
    Bekker A; Schaaf HS; Seifart HI; Draper HR; Werely CJ; Cotton MF; Hesseling AC
    Antimicrob Agents Chemother; 2014; 58(4):2229-34. PubMed ID: 24492365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
    Donald PR; Parkin DP; Seifart HI; Schaaf HS; van Helden PD; Werely CJ; Sirgel FA; Venter A; Maritz JS
    Eur J Clin Pharmacol; 2007 Jul; 63(7):633-9. PubMed ID: 17505821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure.
    Béranger A; Bekker A; Solans BP; Cotton MF; Mirochnick M; Violari A; Wang J; Cababasay M; Wiesner L; Browning R; Moye J; Capparelli EV; Savic RM
    Clin Infect Dis; 2022 Sep; 75(6):1037-1045. PubMed ID: 35134861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
    Jing W; Zong Z; Tang B; Wang J; Zhang T; Wen S; Xue Y; Chu N; Zhao W; Huang H
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.
    Schaaf HS; Parkin DP; Seifart HI; Werely CJ; Hesseling PB; van Helden PD; Maritz JS; Donald PR
    Arch Dis Child; 2005 Jun; 90(6):614-8. PubMed ID: 15908628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants.
    Kiser JJ; Zhu R; DʼArgenio DZ; Cotton MF; Bobat R; McSherry GD; Madhi SA; Carey VJ; Seifart HI; Werely CJ; Fletcher CV
    Ther Drug Monit; 2012 Aug; 34(4):446-51. PubMed ID: 22695364
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid.
    Zhu R; Kiser JJ; Seifart HI; Werely CJ; Mitchell CD; D'Argenio DZ; Fletcher CV
    J Clin Pharmacol; 2012 Apr; 52(4):511-9. PubMed ID: 21558457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
    Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
    Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2.
    Kubota R; Ohno M; Hasunuma T; Iijima H; Azuma J
    Eur J Clin Pharmacol; 2007 Oct; 63(10):927-33. PubMed ID: 17665185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
    Jung JA; Kim TE; Lee H; Jeong BH; Park HY; Jeon K; Kwon OJ; Ko JW; Choi R; Woo HI; Koh WJ; Lee SY
    Drug Des Devel Ther; 2015; 9():5433-8. PubMed ID: 26491254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis.
    Hong BL; D'Cunha R; Li P; Al-Shaer MH; Alghamdi WA; An G; Peloquin C
    Clin Ther; 2020 Nov; 42(11):e220-e241. PubMed ID: 33032843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients.
    Sileshi T; Telele NF; Burkley V; Makonnen E; Aklillu E
    Sci Rep; 2023 Jul; 13(1):11438. PubMed ID: 37454203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic model of isoniazid in patients with tuberculosis in Tunisia.
    Fredj NB; Romdhane HB; Woillard JB; Chickaid M; Fadhel NB; Chadly Z; Chaabane A; Boughattas N; Aouam K
    Int J Infect Dis; 2021 Mar; 104():562-567. PubMed ID: 33476758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of isoniazid in Indian children with tuberculosis.
    Rangari GM; Roy V; Sethi GR; Mishra TK; Khanna A
    Indian J Tuberc; 2015 Apr; 62(2):80-5. PubMed ID: 26117476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?
    Kinzig-Schippers M; Tomalik-Scharte D; Jetter A; Scheidel B; Jakob V; Rodamer M; Cascorbi I; Doroshyenko O; Sörgel F; Fuhr U
    Antimicrob Agents Chemother; 2005 May; 49(5):1733-8. PubMed ID: 15855489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.
    Cordes H; Thiel C; Aschmann HE; Baier V; Blank LM; Kuepfer L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6134-45. PubMed ID: 27480867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review.
    Surarak T; Chumnumwat S; Nosoongnoen W; Tragulpiankit P
    Clin Transl Sci; 2024 Apr; 17(4):e13795. PubMed ID: 38629592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.
    Balhara A; Singh S
    Pharm Res; 2021 Sep; 38(9):1485-1496. PubMed ID: 34518943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rapid Pharmacogenomic Assay to Detect
    Verma R; Patil S; Zhang N; Moreira FMF; Vitorio MT; Santos ADS; Wallace E; Gnanashanmugam D; Persing DH; Savic RM; Croda J; Andrews JR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1317-1326. PubMed ID: 34375564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.